Overview

Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations

Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
Gastroesophageal reflux disease is a common problem in cystic fibrosis (CF). It may lead to worsening lung function and more respiratory infections for a person with CF. This study will look at treating GERD with a medication, esopmeprazole. The medication stops stomach acid from being made. The study will see if there are fewer respiratory infections and improved lung function in patients with CF when taking esomeprazole.
Phase:
Phase 2
Details
Lead Sponsor:
Columbia University
Treatments:
Esomeprazole
Proton Pump Inhibitors